noroviru
infect
constitut
primari
caus
acut
viral
gastroenter
current
vaccin
norovirusspecif
antivir
therapeut
avail
manag
noroviru
infect
noroviru
proteas
essenti
viral
replic
consequ
inhibit
enzym
fruit
avenu
investig
may
lead
emerg
antinoroviru
therapeut
describ
herein
optim
dipeptidyl
inhibitor
noroviru
proteas
use
iter
sar
xray
crystallograph
enzym
cellbas
studi
also
demonstr
herein
vivo
efficaci
inhibitor
use
murin
model
noroviru
infect
access
code
coordin
structur
factor
noroviru
proteas
complex
inhibitor
deposit
protein
databank
access
code
initi
focus
design
peptidyl
transit
state
inhibitor
nv
incorpor
structur
recognit
element
peptidyl
fragment
congruent
known
substrat
specif
enzym
vide
supra
warhead
aldehyd
latent
warhead
bisulfit
adduct
transit
state
mimic
kankanamalag
et
al
synthes
compound
evalu
inhibitori
activ
nv
well
antinoroviru
activ
cellbas
replicon
system
previous
kankanamalag
et
al
order
evalu
specif
interact
enzym
inhibitor
inhibitor
incub
nv
tri
buffer
ph
surprisingli
enzymeinhibitor
complex
form
correspond
complex
form
aldehyd
proteas
format
complex
indic
initi
nonenzymat
buffer
enzymecatalyz
convers
correspond
aldehyd
follow
format
tetrahedr
adduct
activ
site
cystein
studi
aim
ascertain
valid
hypothesi
progress
ensembl
hydrogen
bond
hydrophob
interact
kankanamalag
et
al
human
norovirus
primari
caus
sporad
epidem
acut
gastroenter
us
worldwid
consequ
constitut
import
public
health
problem
well
potenti
bioterror
threat
although
ill
gener
consid
mild
selflimit
incapacit
infect
individu
includ
militari
troop
ship
war
zone
symptomat
phase
norovirus
stabl
environ
refractori
mani
common
disinfect
virion
requir
initi
viru
infect
shed
could
sourc
contamin
therefor
noroviru
outbreak
hard
contain
use
routin
sanit
even
implement
aggress
sanitari
measur
often
fail
prevent
subsequ
outbreak
problem
compound
current
dearth
diagnost
effect
vaccin
norovirusspecif
antivir
therapeut
andor
prophylact
human
norovirus
singlestrand
posit
sens
rna
virus
belong
calicivirida
famili
genogroup
ii
iv
six
genogroup
gigvi
genu
noroviru
known
infect
human
noroviru
genom
kb
consist
three
open
read
frame
encod
kda
polyprotein
major
capsid
protein
small
basic
protein
matur
polyprotein
precursor
process
virusencod
proteas
gener
six
matur
nonstructur
protein
includ
viral
proteas
pro
rna
depend
rna
polymeras
pol
coand
posttransl
process
polyprotein
noroviru
essenti
viru
replic
consequ
noroviru
emerg
potenti
druggabl
target
discoveri
antinoroviru
small
molecul
therapeut
prophylact
noroviru
chymotrypsinlik
cystein
proteas
cyshisglu
catalyt
triad
extend
bind
site
primari
substrat
specif
proteas
glutamin
residu
strong
prefer
defxlqgpsequ
x
h
q
v
correspond
subsit
respect
cleavag
p
p
qg
scissil
bond
recent
report
array
noroviru
inhibitor
includ
acycl
cyclic
sulfamid
piperazin
deriv
also
disclos
first
time
peptidyl
transit
state
ts
inhibitor
ts
mimic
well
macrocycl
inhibitor
effect
enzym
cell
base
assay
furthermor
describ
first
high
throughput
fret
assay
gi
gii
norovirus
screen
tool
identifi
potenti
proteas
inhibitor
determin
high
resolut
xray
crystal
structur
norwalk
viru
nv
prototyp
strain
noroviru
complex
peptidyl
transit
state
inhibitor
well
first
solut
structur
proteas
use
highfield
nmr
final
demonstr
proofofconcept
use
mous
model
murin
noroviru
mnv
infect
vide
infra
continu
foray
area
describ
herein
structurebas
optim
seri
dipeptidyl
inhibitor
nv
repres
structur
figur
use
array
xray
crystallograph
structureact
relationship
biochem
cellbas
anim
studi
use
mous
model
murin
noroviru
mnv
infect
hydroxyphosphon
case
inhibitor
incorpor
aldehyd
function
structur
interact
activ
site
cystein
lead
format
revers
adduct
figur
furthermor
previou
studi
demonstr
noroviru
show
strong
prefer
cyclohexylalanin
consequ
p
cyclohexyl
alanin
residu
well
glutamin
surrog
incorpor
structur
inhibitor
key
bind
interact
noroviru
inhibitor
reveal
determin
high
resolut
xray
crystal
structur
nv
bound
inhibitor
r
cyclohexylmethyl
r
h
xch
oh
na
cocryst
structur
complex
show
crystal
condit
use
bisulfit
revert
precursor
aldehyd
subsequ
form
tetrahedr
adduct
activ
site
cystein
figur
inspect
cocryst
structur
reveal
opportun
addit
bind
interact
effici
use
chemic
structur
specif
one
opportun
recogn
observ
particular
stretch
residu
span
within
benzyl
ring
figur
thu
envisag
incorpor
appropri
function
group
phenyl
ring
could
serv
locu
format
hydrogen
bond
backbon
andor
side
chain
stabil
flexibl
benzyl
segment
increas
bind
affin
format
halogen
bond
also
appear
plausibl
thu
small
focus
librari
compound
synthes
evalu
hypothes
ultim
goal
identif
dipeptidyl
lead
candid
suitabl
conduct
preclin
studi
synthesi
compound
outlin
scheme
reflux
cyclohexylalanin
methyl
ester
hydrochlorid
leucin
methyl
ester
hydrochlorid
trichloromethyl
chloroform
yield
correspond
isocyan
react
appropri
substitut
benzyl
alcohol
yield
carbam
adduct
methyl
ester
hydrolyz
correspond
acid
lithium
hydroxid
aqueou
thf
subsequ
coupl
glutamin
surrog
methyl
ester
hydrochlorid
afford
desir
dipeptidyl
ester
reduc
correspond
alcohol
lithium
borohydrid
dessmartin
oxid
follow
flash
chromatographi
purif
yield
pure
dipeptidyl
aldehyd
enantiomer
puriti
aldehyd
consist
high
amount
epimer
aldehyd
rang
depend
structur
dipeptidyl
aldehyd
reaction
aldehyd
diethyl
phosphit
presenc
diisopropyl
ethyl
amin
yield
correspond
mixtur
epim
correspond
bisulfit
adduct
readili
obtain
white
solid
stir
aldehyd
sodium
bisulfit
ethyl
acetatewat
mixtur
reaction
aldehyd
cyclopropyl
isonitril
follow
dessmartin
oxid
cyclopropyl
amid
yield
desir
synthes
compound
list
tabl
describ
ic
ed
valu
averag
least
two
determin
list
tabl
enzym
select
select
number
inhibitor
evalu
panel
repres
proteas
result
summar
tabl
methodolog
employ
conduct
enzym
assay
inhibit
studi
describ
previous
us
other
vivo
efficaci
compound
evalu
murin
model
noroviru
infect
xray
crystallographi
use
elucid
natur
interact
compound
nv
xray
crystal
structur
nv
reveal
presenc
promin
differ
electron
densiti
substructur
equival
precursor
aldehyd
inhibitor
coval
bound
cy
howev
electron
densiti
observ
hydroxyphosphon
group
present
inhibitor
figur
instead
structur
nv
complex
found
correspond
coval
adduct
precursor
aldehyd
inhibitor
nv
addit
mchlorobenzyl
ring
partial
disord
electron
densiti
region
inhibitor
somewhat
ambigu
interact
nv
inhibitor
shown
figur
mchlorophenyl
ring
inhibitor
occupi
hydrophob
pocket
near
ile
val
van
der
waal
electrostat
surfac
represent
inhibitor
nv
shown
figur
inspect
result
shown
tabl
reveal
gener
dipeptidyl
inhibitor
incorpor
structur
aldehyd
aldehyd
bisulfit
adduct
mask
aldehyd
display
lower
ed
valu
correspond
compound
bear
moieti
furthermor
aldehyd
aldehyd
bisulfit
adductderiv
inhibitor
compar
ed
valu
result
consist
previou
studi
show
activ
aldehyd
bisulfit
adduct
parallel
activ
precursor
aldehyd
f
thing
equal
inhibitor
cyclohexyl
alanin
residu
potent
correspond
tbutyl
glycin
leucin
inhibitor
compar
compound
reveal
xray
crystal
structur
figur
cyclohexyl
alanin
side
chain
optim
fill
hydrophob
subsit
leucin
tbutyl
alanin
side
chain
rang
ring
substitu
explor
enhanc
pharmacolog
activ
compound
halogen
meta
posit
particularli
effect
compound
observ
suggest
involv
halogen
bond
halogen
co
howev
could
demonstr
absolut
certainti
partial
disord
mchlorobenzyl
moieti
enzymeligand
complex
near
ident
observ
aldehyd
inhibitor
r
cyclohexylmethyl
r
h
xcho
figur
initi
evalu
select
carri
use
panel
proteas
four
repres
inhibitor
shown
tabl
compound
display
minim
activ
toward
proteas
digest
blood
coagul
cascad
system
select
uniformli
lower
serin
proteas
human
neutrophil
elastas
hne
compound
use
obtain
preliminari
indic
vivo
efficaci
compound
effect
nv
cell
cultur
also
effect
rang
among
compound
found
effect
ec
valu
nm
note
compound
also
effect
nv
tabl
mice
treatment
compound
significantli
reduc
viru
titer
small
larg
intestin
day
post
viru
infect
respect
compar
untreat
control
group
figur
overal
viru
titer
small
intestin
higher
larg
intestin
reduct
viral
titer
also
greater
small
intestin
larg
intestin
conclus
studi
describ
optim
pharmacolog
activ
select
dipeptidyl
inhibitor
noroviru
proteas
employ
iter
medicin
chemistrysar
studi
xray
crystallographi
vitro
cellbas
screen
vivo
efficaci
studi
importantli
studi
identifi
lead
compound
show
efficaci
murin
model
noroviru
infect
consequ
suitabl
conduct
preclin
studi
reagent
dri
solvent
purchas
variou
chemic
supplier
aldrich
acro
organ
chemimpex
tci
america
bachem
use
obtain
silica
gel
mesh
use
flash
chromatographi
purchas
sorbent
technolog
atlanta
ga
thin
layer
chromatographi
perform
use
analtech
silica
gel
plate
visual
accomplish
use
uv
light
andor
iodin
nmr
spectra
record
cdcl
dmsod
use
varian
spectromet
melt
point
record
meltemp
apparatu
uncorrect
high
resolut
mass
spectrometri
hrm
perform
univers
kansa
mass
spectrometri
lab
use
lct
premier
mass
spectromet
water
milford
equip
time
flight
mass
analyz
electrospray
ion
sourc
puriti
compound
establish
use
hplc
ml
rb
flask
oven
dri
purg
nitrogen
ad
absolut
methanol
ml
solut
cool
ice
bath
kept
nitrogen
atmospher
thionyl
chlorid
ml
ad
cool
methanol
stir
follow
addit
amino
acid
mmol
ice
bath
replac
water
bath
reaction
mixtur
heat
h
stir
remov
solvent
left
white
residu
wash
diethyl
ether
ml
collect
vacuum
filtrat
yield
amino
acid
methyl
ester
hydrochlorid
white
solid
amino
acid
methyl
ester
hydrochlorid
mmol
place
dri
rb
flask
dri
overnight
vacuum
pump
flask
flush
nitrogen
dri
dioxan
ml
ad
follow
trichloromethyl
chloroform
g
mmol
reaction
mixtur
reflux
h
solvent
remov
rotari
evapor
residu
vacuum
distil
yield
pure
isocyan
colorless
oil
solut
substitut
benzyl
alcohol
mmol
dri
acetonitril
ml
treat
triethylamin
g
mmol
follow
amino
acid
methyl
ester
isocyan
mmol
result
solut
reflux
h
allow
cool
room
temperatur
solut
concentr
residu
taken
ethyl
acet
ml
organ
layer
wash
hcl
ml
brine
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
leav
colorless
oil
compound
solut
ester
mmol
tetrahydrofuran
ml
treat
lioh
ml
reaction
mixtur
stir
h
room
temperatur
disappear
ester
monitor
tlc
solvent
evapor
residu
dilut
water
ml
solut
acidifi
ph
use
hydrochlorid
acid
ml
aqueou
layer
extract
ethyl
acet
ml
combin
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yield
compound
colorless
oil
solut
compound
mmol
dri
dmf
ml
ad
edci
g
mmol
eq
hobt
g
mmol
eq
mixtur
stir
minut
room
temperatur
separ
flask
solut
deprotect
glutamin
surrog
g
mmol
dmf
ml
cool
treat
diisopropylethylamin
diea
g
mmol
eq
stir
minut
ad
reaction
mixtur
contain
acid
reaction
mixtur
stir
h
monitor
reaction
tlc
solvent
remov
residu
partit
ethyl
acet
ml
citric
acid
ml
ethyl
acet
layer
wash
satur
aqueou
nahco
ml
follow
satur
nacl
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yield
yellowcolor
oili
product
purif
flash
chromatographi
yield
ester
white
solid
solut
ester
mmol
anhydr
thf
ml
ad
lithium
borohydrid
thf
ml
mmol
dropwis
follow
absolut
ethyl
alcohol
ml
reaction
mixtur
stir
room
temperatur
overnight
reaction
mixtur
acidifi
ad
hcl
ph
adjust
remov
solvent
left
residu
taken
ethyl
acet
ml
organ
layer
wash
brine
ml
dri
anhydr
sodium
sulfat
filter
concentr
yield
compound
white
solid
compound
mmol
dissolv
anhydr
dichloromethan
ml
nitrogen
atmospher
cool
dessmartin
periodinan
reagent
g
mmol
eq
ad
reaction
mixtur
stir
ice
bath
remov
reaction
mixtur
stir
room
temperatur
h
monitor
tlc
indic
complet
disappear
start
materi
solut
aqueou
sodium
thiosulf
ml
ad
solut
stir
anoth
minut
aqueou
layer
remov
organ
layer
wash
aqueou
sodium
thiosulf
ml
follow
satur
aqueou
sodium
bicarbon
ml
water
ml
brine
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
yellow
residu
purifi
flash
chromatographi
silica
gelmethylen
chlorideethyl
acetatemethanol
yield
white
solid
solut
diethylphosphit
mg
mmol
dri
dichloromethan
ml
ad
diea
mg
mmol
follow
solut
aldehyd
mmol
dichloromethan
ml
reaction
mixtur
stir
room
temperatur
h
reaction
mixtur
dilut
dichloromethan
ml
wash
hcl
ml
brine
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
leav
light
yellow
solid
purifi
flash
chromatographi
yield
compound
white
solid
gener
procedureto
solut
aldehyd
mmol
dri
ethyl
acet
ml
ad
absolut
ethanol
ml
stir
follow
solut
sodium
bisulfit
mg
mmol
water
ml
reaction
mixtur
stir
h
reaction
mixtur
allow
cool
room
temperatur
vacuum
filter
solid
thoroughli
wash
absolut
ethanol
filtrat
dri
anhydr
sodium
sulfat
filter
concentr
yield
yellowish
oil
oili
product
treat
ethyl
ether
ml
form
white
solid
white
solid
stir
ethyl
ether
ml
ethyl
acet
ml
minut
care
remov
solvent
use
pipett
left
compound
white
solid
solut
aldehyd
mmol
ethyl
acet
ml
kept
treat
acet
acid
g
mmol
follow
cyclopropyl
isocyanid
g
mmol
reaction
mixtur
stir
room
temperatur
h
solut
concentr
vacuo
residu
dissolv
methanol
ml
treat
solut
k
co
g
mmol
water
ml
reaction
mixtur
stir
room
temperatur
h
methanol
evapor
aqueou
layer
extract
ethyl
acet
ml
combin
organ
layer
wash
hcl
ml
brine
ml
organ
layer
dri
anhydr
sodium
sulfat
solvent
remov
yield
compound
white
solid
use
next
step
without
purif
solut
compound
mmol
anhydr
dichloromethan
ml
cool
kept
nitrogen
atmospher
ad
dessmartin
periodinan
reagent
g
mmol
eq
stir
ice
bath
remov
reaction
mixtur
stir
room
temperatur
h
reaction
monitor
tlc
start
materi
disappear
solut
aqueou
sodium
thiosulf
ml
ad
solut
stir
minut
solut
pour
separatori
funnel
aqueou
layer
remov
organ
layer
wash
aqueou
sodium
thiosulf
ml
follow
satur
aqueou
sodium
bicarbon
ml
water
ml
brine
ml
organ
layer
dri
anhydr
sodium
sulfat
filter
concentr
leav
yellow
solid
purifi
flash
chromatographi
silica
gelmethylen
chlorideethyl
acetatemethanol
yield
white
solid
fluorobenzyl
cyclopropylamino
amino
studi
carri
describ
previous
purifi
nv
mm
nacl
mm
pb
ph
mm
dtt
concentr
mgml
use
prepar
noroviru
proteasecompound
complex
stock
solut
mm
compound
prepar
dmso
nv
inhibitor
complex
prepar
mix
mm
mm
nv
incub
ice
h
mixtur
load
onto
superdex
gl
column
equilibr
mm
nacl
mm
tri
ph
sampl
concentr
mgml
vivaproduct
inc
concentr
crystal
screen
crystal
experi
conduct
compact
jr
rigaku
reagent
sit
drop
vapor
diffus
plate
use
equal
volum
protein
crystal
solut
equilibr
latter
crystal
nv
display
needl
morpholog
obtain
overnight
proplex
ht
screen
molecular
dimens
condit
wv
peg
mme
mm
tri
ph
mm
ammonium
sulfat
sampl
transfer
fresh
drop
compos
crystal
solut
peg
glycerol
store
liquid
nitrogen
two
crystal
form
nv
complex
display
prismat
morpholog
observ
day
wizard
screen
emerald
biosystem
primit
hexagon
nv
form
obtain
condit
wv
mm
ammonium
citrat
primit
orthorhomb
nv
wv
mm
sodium
thiocyan
sampl
transfer
fresh
drop
compos
crystal
solut
peg
store
liquid
nitrogen
prior
data
collect
xray
diffract
data
collect
advanc
photon
sourc
beamlin
use
dectri
pilatu
pixel
array
detector
intens
integr
use
xd
laue
class
analysi
data
scale
perform
aimless
suggest
highest
probabl
laue
class
possibl
space
group
nv
nv
nv
matthew
coeffici
suggest
singl
molecul
asymmetr
unit
da
structur
solut
conduct
molecular
replac
phaser
use
previous
determin
structur
inhibitor
bound
nv
pdb
search
model
space
group
point
symmetri
test
top
solut
obtain
space
group
use
point
forward
nv
isomorph
pdb
structur
refin
use
manual
model
build
conduct
phenix
coot
respect
disord
side
chain
truncat
point
electron
densiti
could
observ
structur
valid
conduct
molprob
figur
prepar
use
packag
cell
mous
macrophag
cell
line
maintain
dulbecco
minimum
essenti
medium
dmem
contain
antibiot
chlortetracyclin
penicillin
uml
streptomycin
presenc
fetal
bovin
serum
obtain
h
virgin
washington
univers
st
loui
mo
antivir
activ
compound
cell
cultur
determin
cell
compound
dissolv
dmso
make
mm
stock
solut
amount
dmso
cell
cultur
exceed
stock
solut
serial
dilut
cell
cultur
media
prior
addit
confluent
monolay
cell
plate
cell
immedi
infect
viru
multipl
infect
moi
incub
cell
h
cell
frozen
thaw
viru
titer
determin
tissu
cultur
infecti
dose
tcid
method
effect
concentr
ec
valu
determin
graphpad
prism
graphpad
softwar
san
diego
ca
nonlinear
regress
analys
doserespons
curv
inhibit
viru
replic
log
inhibitor
concentr
variabl
slope
anim
experi
anim
studi
perform
accord
protocol
approv
institut
anim
care
use
committe
iacuc
kansa
state
univers
balbc
mice
purchas
charl
river
lab
wilmington
seven
eight
weekold
femal
balbc
mice
inocul
intraperiton
tcid
mous
mice
periton
given
drug
vehicl
etoh
compound
mgkgday
divid
two
dose
per
day
compound
administr
start
h
prior
viru
infect
continu
daili
mice
euthan
day
post
infect
dpi
mice
sacrif
small
larg
intestin
tract
collect
intestin
place
pb
intestin
content
gentli
remov
squeez
tissu
homogen
pb
ml
small
larg
intestin
respect
frozen
readi
use
viru
titer
homogen
supernat
determin
tcid
method
statist
analysi
perform
logtransform
tcid
valu
use
twotail
student
ttest
p
fold
chang
geometr
mean
liver
viru
titer
group
calcul
divid
viru
titer
control
group
treat
group
hydrogen
bond
interact
inhibitor
chain
b
nv
ligand
precursor
aldehyd
inhibitor
side
chain
residu
color
cyan
inhibitor
color
gray
water
molecul
repres
red
sphere
hydrogen
bond
repres
dash
line
water
mediat
contact
solid
line
residu
span
locat
near
benzyl
ring
precursor
aldehyd
inhibitor
surfac
represent
precursor
aldehyd
compound
bound
nv
neighbor
residu
nv
color
yellow
nonpolar
white
weakli
polar
cyan
polar
activ
nv
proteas
noroviru
cellbas
replicon
cell
tabl
select
select
compound
panel
proteas
tabl
crystallograph
data
nv
inhibitor
structur
